Related Experiment Videos

Myocardial scintigraphy with 123I-labelled heptadecanoic acid in patients with unstable angina pectoris

Insights

123I-heptadecanoic acid (123I-HA) effectively detects myocardial ischemia in unstable angina patients. This imaging agent reveals distinct metabolic turnover rates, differentiating ischemic areas from infarcted regions.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Medical Imaging

Background:

  • 123I-heptadecanoic acid (123I-HA) is used to calculate metabolic turnover rates for detecting regional myocardial ischemia.
  • Previous studies established different turnover rates in stable angina versus myocardial infarction.

Purpose of the Study:

  • To assess the utility of 123I-HA in identifying myocardial ischemia in patients with unstable angina.
  • To compare 123I-HA turnover rates in unstable angina with those in myocardial infarction.

Main Methods:

  • Twelve patients with unstable angina were studied.
  • Turnover rates were derived from time-activity curves and expressed as half-time (t 1/2) in minutes.
  • Imaging defects and myocardial regions were analyzed.

Main Results:

  • Eight patients exhibited imaging defects in 12 myocardial regions; four patients showed no defects.
  • Regions with accumulation defects displayed significantly increased t 1/2 values (45.4 ± 4.8 min) compared to normally perfused zones (29.1 ± 3.6 min).

Conclusions:

  • 123I-HA can successfully identify ischemic areas of the myocardium in patients with unstable angina.
  • The metabolic turnover of 123I-HA in unstable angina differs from that observed in myocardial infarction.

Related Concept Videos